| P2093 | author name string | Frank O Nestle | |
| | Günter Burg | |
| | Nicola Pimpinelli | |
| | Gianni Gerlini | |
| | Adrian Tun-Kyi | |
| | Christa Dudli | |
| P2860 | cites work | Isolation and characterization of a cDNA and gene coding for a fourth CD1 molecule | Q24628876 |
| | Dendritic cells and the control of immunity | Q27860918 |
| | Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10. | Q30763343 |
| | T cell mediated immunity to Mycobacterium tuberculosis | Q33536568 |
| | The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids | Q33652486 |
| | Regulatory activity of autocrine IL-10 on dendritic cell functions | Q33938563 |
| | Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients | Q34619348 |
| | The CD1 family and T cell recognition of lipid antigens | Q35030902 |
| | Gangliosides as therapeutic targets for cancer | Q35128665 |
| | Role of tumor-associated gangliosides in cancer progression | Q35138120 |
| | Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells | Q35764615 |
| | Molecular recognition of lipid antigens by T cell receptors | Q35834577 |
| | Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells | Q36096376 |
| | High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. | Q36367196 |
| | Serological survey of normal humans for natural antibody to cell surface antigens of melanoma | Q36399013 |
| | Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma | Q36763316 |
| | Biochemical studies of the human thymocyte cell-surface antigens T6, T9 and T10. | Q39109889 |
| | Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine | Q40563512 |
| | Ganglioside metabolism: enzymology, topology and regulation. | Q40670432 |
| | Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma | Q40759621 |
| | Carbohydrate vaccines that induce antibodies against cancer. 2. Previous experience and future plans | Q40879087 |
| | Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 |
| | Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. | Q40971390 |
| | CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool | Q40981431 |
| | Differential effects of cytolytic T cell subsets on intracellular infection | Q41105124 |
| | Immunosuppression by human gangliosides. II. Carbohydrate structure and inhibition of human NK activity | Q41141607 |
| | Structure and function of the CD1 family of MHC-like cell surface proteins | Q41144404 |
| | Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. | Q41411454 |
| | Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. | Q41453118 |
| | Lipid Composition of Human Malignant Melanoma Tumors at Various Levels of Malignant Growth | Q41554341 |
| | Humoral immune response in disease-free advanced melanoma patients after vaccination with melanoma-associated gangliosides. EORTC Cooperative Melanoma Group | Q41653445 |
| | Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells | Q41715003 |
| | CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen | Q41939036 |
| | Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma | Q42858939 |
| | A monoclonal antibody recognizing a human thymus leukemia-like antigen associated with beta 2-microglobulin | Q44684750 |
| | Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines | Q44687018 |
| | Studies of a ganglioside fraction extracted from human malignant melanoma | Q45187812 |
| | IgM anti-ganglioside antibodies induced by melanoma cell vaccine correlate with survival of melanoma patients. | Q45964133 |
| | CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity. | Q46745431 |
| | Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K/Akt pathway and of IkappaB kinase activity | Q47685303 |
| | Regulation of CD1d expression by murine tumor cells: Escape from immunosurveillance or alternate target molecules? | Q57209303 |
| | Bacillus Calmette-Guerin Down-Regulates CD1b Induction by Granulocyte-Macrophage Colony Stimulating Factor in Human Peripheral Blood Monocytes | Q61320429 |
| | Gangliosides of human melanoma | Q68746933 |
| | Human monoclonal antibody to ganglioside GM2 for melanoma treatment | Q69368376 |
| | Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside | Q69383994 |
| | Immunogenicity of melanoma-associated gangliosides in cancer patients | Q70110613 |
| | Interleukin-10 production in malignant melanoma: preferential detection of IL-10-secreting tumor cells in metastatic lesions | Q71119379 |
| | B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10 | Q71677079 |
| | Differential effects of interleukin‐10 on the expression of HLA class II and CD1 molecules induced by granulocyte/macrophage colony‐stimulating factor/interleukin‐4 | Q71815122 |
| | Interleukin‐10 differentially regulates B7‐1 (CD80) and B7‐2 (CD86) expression on human peripheral blood dendritic cells | Q71815204 |
| | Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma | Q72203307 |
| | Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance | Q72230111 |
| | Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside | Q72377535 |
| | Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer | Q73311980 |
| | Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules | Q73404323 |
| | Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function | Q73482930 |
| | Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells | Q73521253 |
| | Clinical significance of defective dendritic cell differentiation in cancer | Q73803370 |
| | Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma | Q73839567 |
| | Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma | Q73850975 |
| | Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo | Q73863756 |
| | IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis | Q73948786 |
| | Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions | Q74179201 |
| | Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells | Q74310288 |
| | Cd1d is expressed on dermal dendritic cells and monocyte-derived dendritic cells | Q74531146 |
| | The CD1 family of lipid antigen-presenting molecules | Q77111824 |
| | Extracellular signal-regulated kinase, stress-activated protein kinase/c-Jun N-terminal kinase, and p38mapk are involved in IL-10-mediated selective repression of TNF-alpha-induced activation and maturation of human peripheral blood monocyte-derived | Q77320323 |
| | Immune escape mechanisms in malignant melanoma | Q77721498 |
| | Ganglioside vaccines with emphasis on GM2 | Q77726277 |
| | Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide | Q78145103 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| | metastatic melanoma | Q18975855 |
| P304 | page(s) | 1853-1863 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions | |
| P478 | volume | 165 | |